10A NCAC 41A .0107 – Reporting of COVID-19 Diagnostic Test Results

10A NCAC 41A .0107 governs the reporting of COVID-19 diagnostic test results by laboratories to public health officials. This rule requires that reports be made in compliance with the requirements set forth in the United States Department of Health and Human Services' COVID-19 Pandemic Response, Laboratory Data Reporting: CARES Act Section 18115 guidance, which is no longer in effect now that the federal Public Health Emergency has ended. Given that case and test reporting have become less representative of COVID-19 activity in the community due to the widespread use of home testing and the existence of other surveillance systems that are now providing more timely and complete data for public health action, this rule is no longer needed and is proposed for repeal. The proposed effective date of this repeal is October 1, 2023.

A public hearing will be held on Friday, July 7, 2023 at 2:00 p.m. The public hearing will be held by teleconference. You may participate in the public hearing by dialing 919-715-0769 (no access code).

Proposed Rule:	10A NCAC 41A .0107
Notice:	Notification of Proposed Rule Repeal: 10A NCAC 41A .0107
Fiscal Note:	N/A
Federal Certification:	N/A

Public Comments

The public comment period runs from June 1, 2023 to July 31, 2023. Comments will also be accepted at the public hearing.

Additional Links

Procedure for Subjecting a Proposed Rule to Legislative Review